Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy (2019)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1182/bloodadvances.2019000627
- Subjects: TRANSPLANTE HOMÓLOGO; LINFÓCITOS T; LEUCEMIA MIELOIDE AGUDA; DOENÇAS DA MEDULA ÓSSEA; DOENÇA ENXERTO-HOSPEDEIRO; FÁRMACOS IMUNOSSUPRESSORES; CONDICIONAMENTO; SOBREVIVÊNCIA LIVRE DE DOENÇA; ESTUDOS RETROSPECTIVOS
- Agências de fomento:
- Financiado pelo ONR
- Health Resources and Services Administration (US Department of Health and Human Services)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [HHSH250201200016C]
- National Institute of Allergy and Infectious Diseases, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [5U24-CA076518]
- National Heart, Lung, and Blood Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U24-CA076518, 5U10HL069294]
- National Cancer Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5U24-CA076518, 5U10HL069294]
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2019
- Source:
- Título do periódico: Blood advances
- ISSN: 2473-9529
- Volume/Número/Paginação/Ano: v. 3, n. 19, p. 2836-2844, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
-
ABNT
SOLOMON, Scott R et al. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, v. 3, n. 19, p. 2836-2844, 2019Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2019000627. Acesso em: 11 maio 2024. -
APA
Solomon, S. R., Martin, A. S., Shah, N. N., Fatobene, G., Malki, M. M. A., Ballen, K. K., et al. (2019). Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, 3( 19), 2836-2844. doi:10.1182/bloodadvances.2019000627 -
NLM
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha V. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2024 maio 11 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627 -
Vancouver
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha V. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2024 maio 11 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627 - Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis
- Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
- Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria
- Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population
- Prevalence of SMIM1 c.64_80del17 homozygotes in southeastern Brazil [Carta]: the Vel-negative phenotype
- Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
- Current role of interferon in hairy cell leukemia therapy: a timely decision
- Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.[Carta]
- Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis
- Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay
Informações sobre o DOI: 10.1182/bloodadvances.2019000627 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
